Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Scilla Martima Gran(3ch-30ch) 3 Ch Tablet is a Health Canada–registered human drug (DIN 01952862) held by Homeocan Inc., containing Squill. Health Canada lists its status as Cancelled Post Market (status date 15 Oct 1997). Nexara Health has matched 3 registrations of Squill across 1 other regulated market.

Health Canada registration

DIN01952862
Brand nameScilla Martima Gran(3ch-30ch)
Active ingredientSquill
Strength3 Ch
Dosage formTablet
RouteOral
CompanyHomeocan Inc.
StatusCancelled Post Market — 15 Oct 1997
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Squill registered in other markets

3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
Hong KongExtract For Making Squill Liq ExtractTranso-Pharm (Hong Kong) LimitedRegisteredDH Drug Office
Hong KongSquill Liquid Extract BPTranso-Pharm (Hong Kong) LimitedRegisteredDH Drug Office
Hong KongSquill OxymelTranso-Pharm (Hong Kong) LimitedRegisteredDH Drug Office

See every manufacturer of Squill worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Scilla Martima Gran(3ch-30ch) (DIN 01952862) marketed in Canada?

No. Health Canada lists DIN 01952862 as Cancelled Post Market as of 15 Oct 1997.

Who holds the Canadian licence for this product?

Homeocan Inc. is the company of record in the Health Canada Drug Product Database.

Is Squill registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 01952862, status date 1997-10-15; national medicine registries: DH Drug Office. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 01952862, status date 1997-10-15; national medicine registries: DH Drug Office.

Health Canada Drug Product Database (DPD), DIN 01952862, status date 1997-10-15; national medicine registries: DH Drug Office. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.